Annual CFI
-$93.10 K
-$93.10 K-100.00%
December 31, 2023
Summary
- As of February 22, 2025, APRE annual cash flow from investing activities is -$93.10 thousand, with the most recent change of -$93.10 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, APRE annual CFI has fallen by -$67.40 thousand (-262.26%).
Performance
APRE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
+$7500.00+100.00%
September 30, 2024
Summary
- As of February 22, 2025, APRE quarterly cash flow from investing activities is $0.00, with the most recent change of +$7500.00 (+100.00%) on September 30, 2024.
- Over the past year, APRE quarterly CFI has increased by +$8000.00 (+100.00%).
- APRE quarterly CFI is now -100.00% below its all-time high of $2000.00, reached on June 30, 2020.
Performance
APRE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$22.70 K
+$85.90 K+79.10%
September 30, 2024
Summary
- As of February 22, 2025, APRE TTM cash flow from investing activities is -$22.70 thousand, with the most recent change of +$85.90 thousand (+79.10%) on September 30, 2024.
- Over the past year, APRE TTM CFI has increased by +$78.40 thousand (+77.55%).
Performance
APRE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
APRE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +100.0% | +77.5% |
| 3 y3 years | -262.3% | 0.0% | -39.3% |
| 5 y5 years | -2416.2% | +100.0% | +26.5% |
APRE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | at high | +100.0% | <-9999.0% | +79.1% |
| 5 y | 5-year | <-9999.0% | at low | -100.0% | +100.0% | <-9999.0% | +79.1% |
| alltime | all time | <-9999.0% | +70.6% | -100.0% | +100.0% | <-9999.0% | +79.1% |
Aprea Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | -$22.70 K(-79.1%) |
| Jun 2024 | - | -$7500.00(-6.3%) | -$108.60 K(+7.4%) |
| Mar 2024 | - | -$8000.00(+11.1%) | -$101.10 K(+8.6%) |
| Dec 2023 | -$93.10 K(<-9900.0%) | -$7200.00(-91.6%) | -$93.10 K(+8.4%) |
| Sep 2023 | - | -$85.90 K(<-9900.0%) | -$85.90 K(<-9900.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2021 | - | $0.00(0.0%) | -$16.30 K(+4.5%) |
| Jun 2021 | - | $0.00(0.0%) | -$15.60 K(+14.7%) |
| Mar 2021 | - | $0.00(-100.0%) | -$13.60 K(-47.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$25.70 K(-16.8%) | -$16.30 K(-2428.6%) | -$25.80 K(+7.5%) |
| Sep 2020 | - | $700.00(-65.0%) | -$24.00 K(-31.2%) |
| Jun 2020 | - | $2000.00(-116.4%) | -$34.90 K(-19.0%) |
| Mar 2020 | - | -$12.20 K(-15.9%) | -$43.10 K(+39.5%) |
| Dec 2019 | -$30.90 K(+735.1%) | -$14.50 K(+42.2%) | -$30.90 K(+88.4%) |
| Sep 2019 | - | -$10.20 K(+64.5%) | -$16.40 K(+164.5%) |
| Jun 2019 | - | -$6200.00(<-9900.0%) | -$6200.00(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | -$3700.00(<-9900.0%) | - | - |
| Dec 2017 | $0.00(0.0%) | - | - |
| Jun 2008 | $0.00(-100.0%) | - | - |
| Jun 2007 | -$316.60 K(+1751.5%) | - | - |
| Jun 2006 | -$17.10 K(<-9900.0%) | - | - |
| Dec 2004 | $0.00 | - | - |
FAQ
- What is Aprea Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Aprea Therapeutics?
- What is Aprea Therapeutics annual CFI year-on-year change?
- What is Aprea Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly CFI year-on-year change?
- What is Aprea Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aprea Therapeutics?
- What is Aprea Therapeutics TTM CFI year-on-year change?
What is Aprea Therapeutics annual cash flow from investing activities?
The current annual CFI of APRE is -$93.10 K
What is the all time high annual CFI for Aprea Therapeutics?
Aprea Therapeutics all-time high annual cash flow from investing activities is $0.00
What is Aprea Therapeutics annual CFI year-on-year change?
Over the past year, APRE annual cash flow from investing activities has changed by -$93.10 K (-100.00%)
What is Aprea Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of APRE is $0.00
What is the all time high quarterly CFI for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly cash flow from investing activities is $2000.00
What is Aprea Therapeutics quarterly CFI year-on-year change?
Over the past year, APRE quarterly cash flow from investing activities has changed by +$8000.00 (+100.00%)
What is Aprea Therapeutics TTM cash flow from investing activities?
The current TTM CFI of APRE is -$22.70 K
What is the all time high TTM CFI for Aprea Therapeutics?
Aprea Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is Aprea Therapeutics TTM CFI year-on-year change?
Over the past year, APRE TTM cash flow from investing activities has changed by +$78.40 K (+77.55%)